Miltenyi Biotec GmbH-医療機器分野:企業M&A・提携分析

◆英語タイトル:Miltenyi Biotec GmbH - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010932
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Miltenyi Biotec GmbH (Miltenyi) is a biotechnology company which provides biomedical research and cellular therapy products for cell isolation, flow cytometry, sample preparation and cell culture. The company’s services include sample preparation, cell separation, flow cytometry, cell culture and stimulation, molecular, clinical applications and viscover imaging. It also offers cytometers, analyzers, reagents, buffers, imaging instruments, and software solutions. Miltenyi conducts research in the areas of oncology, cardiovascular disease, metabolic disorders, immunology, neurology and infection. The company has presence in Germany, the US, the UK, France, Italy, Singapore, Japan, South Korea, and others. Miltenyi is headquartered in Bergisch Gladbach, North Rhine-Westphalia, Germany.

Miltenyi Biotec GmbH – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Miltenyi Biotec GmbH, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Miltenyi Biotec GmbH, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Miltenyi Biotec GmbH, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Miltenyi Biotec GmbH, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Miltenyi Biotec GmbH, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Miltenyi Biotec GmbH, Medical Equipment, Deal Details 10
Partnerships 10
Cesca Therapeutics Enters into Distribution Agreement with Miltenyi Biotec 10
Miltenyi Biotec Enters Into Distribution Agreement With Tree Star 11
Applied Microarrays Enters Into Co-Development Agreement With Sensovation For FlexiPlex Array System 12
Acquisition 13
Miltenyi Biotec Acquires Sensovation 13
Miltenyi Biotec Acquires Owl Biomedical, Disposable Cell Sorting Technology Provider 14
Miltenyi Biotec GmbH – Key Competitors 15
Miltenyi Biotec GmbH – Key Employees 16
Miltenyi Biotec GmbH – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 19
Legal and Regulatory 19
Sep 19, 2016: CE marked MACS IVD Antibodies by Miltenyi Biotec – Compliant with IVDD and produced according to ISO 13485 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Miltenyi Biotec GmbH, Medical Equipment, Key Facts 2
Miltenyi Biotec GmbH, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Miltenyi Biotec GmbH, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Miltenyi Biotec GmbH, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Miltenyi Biotec GmbH, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Miltenyi Biotec GmbH, Deals By Market, 2011 to YTD 2017 8
Miltenyi Biotec GmbH, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Cesca Therapeutics Enters into Distribution Agreement with Miltenyi Biotec 10
Miltenyi Biotec Enters Into Distribution Agreement With Tree Star 11
Applied Microarrays Enters Into Co-Development Agreement With Sensovation For FlexiPlex Array System 12
Miltenyi Biotec Acquires Sensovation 13
Miltenyi Biotec Acquires Owl Biomedical, Disposable Cell Sorting Technology Provider 14
Miltenyi Biotec GmbH, Key Competitors 15
Miltenyi Biotec GmbH, Key Employees 16
Miltenyi Biotec GmbH, Other Locations 17
Miltenyi Biotec GmbH, Subsidiaries 17

★海外企業調査レポート[Miltenyi Biotec GmbH-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Methaq Takaful Insurance Company:企業の戦略・SWOT・財務情報
    Methaq Takaful Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Methaq Takaful Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Lexicon Pharmaceuticals Inc (LXRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Lexicon Pharmaceuticals Inc (Lexicon) is a biopharmaceutical company, which focuses on the discovery, development and commercialization of innovative treatments for human diseases. The company has advanced multiple drug candidates into clinical development and has clinical-stage drug program …
  • EV Energy Partners LP:企業のM&A・事業提携・投資動向
    EV Energy Partners LP - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EV Energy Partners LP Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Deutsche Telekom AG:戦略・SWOT・企業財務分析
    Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • H.I.G. Capital LLC:企業の戦略的SWOT分析
    H.I.G. Capital LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Sunstar Holding AG:戦略・SWOT・企業財務分析
    Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report Summary Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Grifols SA (GRF)-製薬・医療分野:企業M&A・提携分析
    Summary Grifols SA (Grifols) focuses at improving the health and well-being of people around the world. It carries out the research, development, manufacturing and marketing of plasma-derived therapies, hospital pharmacy products and diagnostic technology for clinical use. The company specializes in …
  • Montana Tech Components AG:企業の戦略・SWOT・財務情報
    Montana Tech Components AG - Strategy, SWOT and Corporate Finance Report Summary Montana Tech Components AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Bioasis Technologies Inc (BTI):企業の財務・戦略的SWOT分析
    Summary Bioasis Technologies Inc (BTI) is a developer and commercialize of pharmaceutical products and diagnostic technologies for central nervous system diseases and disorders. The company’s transcend program describes the proprietary carrier, p97 to deliver therapeutics and imaging agents across t …
  • PageGroup plc (PAGE):企業の財務・戦略的SWOT分析
    PageGroup plc (PAGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Constellation Brands, Inc.:戦略・SWOT・企業財務分析
    Constellation Brands, Inc. - Strategy, SWOT and Corporate Finance Report Summary Constellation Brands, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Jadason Enterprises Ltd (J03):企業の財務・戦略的SWOT分析
    Jadason Enterprises Ltd (J03) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Centogene AG-製薬・医療分野:企業M&A・提携分析
    Summary Centogene AG (Centogene) is a provider of genetic testing services. The company offers genetic testing for rare hereditary disorders. It offers whole genome sequencing, whole exome sequencing, biomarker and biochemical testing; prenatal testing, DNA extraction and cell culture services. Cent …
  • Birla Corporation Ltd:企業の戦略・SWOT・財務情報
    Birla Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Birla Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Cyxone AB (CYXO):製薬・医療:M&Aディール及び事業提携情報
    Summary Cyxone AB (Cyxone) is a biopharmaceutical company that develops cyclotide drugs for immune-related diseases. The company develops T20K, a compound to inhibit pro-inflammatory cytokines, such as IL2 that helps to reduce clinical symptoms in an animal model for multiple sclerosis after oral ad …
  • FutureFuel Corp (FF):企業の財務・戦略的SWOT分析
    FutureFuel Corp (FF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Supernus Pharmaceuticals Inc (SUPN):企業の財務・戦略的SWOT分析
    Supernus Pharmaceuticals Inc (SUPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • EMCOR Group, Inc.:企業の戦略・SWOT・財務情報
    EMCOR Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary EMCOR Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Heliatek GmbH-エネルギー分野:企業M&A・提携分析
    Summary Heliatek GmbH (Heliatek) is a solar energy company that manufactures and constructs organic photovoltaics. The company manufactures modules on flexible substrates utilizing a roll-to-roll production process. Its products include OPV oligomers, OPV polymers, and OPV dye-sensitized solar cells …
  • Teledyne Technologies Incorporated:企業の戦略・SWOT・財務情報
    Teledyne Technologies Incorporated - Strategy, SWOT and Corporate Finance Report Summary Teledyne Technologies Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆